Cambridge, MA, United States of America

David Reid

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Modernatx, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Reid - Innovator in Coronavirus Vaccine Development

Introduction

David Reid is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of vaccine development, particularly in the fight against coronavirus. His innovative work has led to the creation of a patent that addresses critical health challenges.

Latest Patents

David Reid holds a patent for "Variant Strain-Based Coronavirus Vaccines." This patent represents a crucial advancement in the development of vaccines that can effectively target various strains of the coronavirus. His work in this area is vital for public health and safety.

Career Highlights

David Reid is currently employed at ModernaTX, Inc., a leading biotechnology company known for its groundbreaking work in mRNA technology and vaccine development. His role at the company allows him to contribute to cutting-edge research and innovation in the medical field.

Collaborations

David has collaborated with notable colleagues, including Andrea Carfi and Guillaume Stewart-Jones. These partnerships have enhanced the research and development process, leading to more effective solutions in vaccine technology.

Conclusion

David Reid's contributions to the field of vaccine development, particularly through his patent on coronavirus vaccines, highlight his importance as an inventor. His work continues to impact public health positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…